View List of publications (PDF, 232 KB)

Abstracts from recent conferences

Abstract # 0638 Impact of DNA repair proteins on cell survival in response to damage induced by the DNA self-strand-breaking nucleoside analogue CNDAC, View full details (PDF, 140 KB)

Abstract # 0651 The Basis of Cell Sensitivity to Aurora A/B Inhibitors. View full details (PDF, 175 KB)

Abstract # 0801 Optimal cancer chronotherapeutic schedules of Seliciclib revealed by a systems biology approach. View full details (PDF, 816 KB)

Abstract # 1645 Systems biology analysis of CYC116, a novel aurora kinase inhibitor. View full details (PDF, 875 KB)

Abstract # 4015 Combination studies with the oral Aurora kinase inhibitor CYC116 and chemotherapeutic agents. View full details (PDF, 295 KB)

Abstract # 5511 Therapeutic Efficacy of Seliciclib in Combination with Ionizing Radiation for Human Nasopharyngeal Carcinoma. View full details (PDF, 673 KB)

Abstract # 5644 Anti-tumor activity of CYC116, a novel small molecule inhibitor of Aurora kinases and VEGFR2. View full details (PDF, 222 KB)

Abstract # 5645 In vivo mode of action of CYC116, a novel small molecule inhibitor of Aurora kinases and VEGFR2. View full details (PDF, 184 KB)